This company listing is no longer active
TIKR.F Stock Overview
Tikcro Technologies Ltd. focuses on development of biotechnology project in Israel.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Tikcro Technologies Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.28 |
| 52 Week High | US$0.30 |
| 52 Week Low | US$0.11 |
| Beta | 0 |
| 1 Month Change | 154.55% |
| 3 Month Change | n/a |
| 1 Year Change | 64.71% |
| 3 Year Change | 75.00% |
| 5 Year Change | -17.89% |
| Change since IPO | -99.43% |
Recent News & Updates
Recent updates
Shareholder Returns
| TIKR.F | US Biotechs | US Market | |
|---|---|---|---|
| 7D | -3.4% | -4.2% | -3.7% |
| 1Y | 64.7% | -2.0% | 20.5% |
Return vs Industry: TIKR.F exceeded the US Biotechs industry which returned 5.8% over the past year.
Return vs Market: TIKR.F exceeded the US Market which returned -10.9% over the past year.
Price Volatility
| TIKR.F volatility | |
|---|---|
| TIKR.F Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 11.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: TIKR.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine TIKR.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | n/a | Aviv Boim | www.tikcro.com |
Tikcro Technologies Ltd. focuses on development of biotechnology project in Israel. It offers anti-cytotoxic T-lymphocyte-associated protein 4 for cancer immune treatment. The company was formerly known as Tioga Technologies Ltd.
Tikcro Technologies Ltd. Fundamentals Summary
| TIKR.F fundamental statistics | |
|---|---|
| Market cap | US$2.77m |
| Earnings (TTM) | -US$478.00k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs TIKR.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TIKR.F income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$478.00k |
| Earnings | -US$478.00k |
Last Reported Earnings
Dec 31, 2020
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did TIKR.F perform over the long term?
See historical performance and comparison